The team is considered a straight look and modification protein Igroops
They can see the first -time triggering Parkinson's disease in human tissues
Protein units and measurement of protein assemblies considered a trigger of neurodiating disease
For the first time, scientists managed and measured directly in the human brain, the small hands of proteins considered to be responsible for Parkinson activated.This finding, published in Nature Biomedical Biomedical Humanity, is a decisive progress in a study of a disease that affects more than 166,000 people in the UK and at global level, can double their circulation rate until they reach 25 million patients in 2050.
These clusters, called alpha-Synulein oligomers, were in the case of the tribe, but were invisible so far.“It's like seeing stars in daylight, scientists scientists, research cooperation.
The work is guided by the University of London College (UCL), the Francis of the Scream and Polytechnic Monsiscopy Homes-PD.Their small nanometer.
Researchers compare the post -Mortem fabric of Parkinson's patients at a healthy age at the same age.They found aligomers in both groups, but the brain disease is large, bright and many.In addition, they only identified a subclass of aligomers present in patients, which may be the first visible disease signal.
For more than a century, Drug has been recognized as a characteristic of Parkinson - due to protein deposits.These appear when the disease progresses already."Levi's bodies tell us where the disease is, now where it is, says Professor Steven Lee, who directed the study.
The new approach will allow Parkinson to look at its earliest stages and open the way for the diagnoses and early treatments capable of stopping the disease, something does not exist so far.
Atlas for some lies
Significant progresses have not added to Parkinson.Ende Lucius Weiss, so Polytechnique is a needle in the weed, but now we know of the dead, "who knows.
The study supported the Michael Fox Fox Foundation, in addition to donating brain tissue to the British Parkinson Study (ASAP) and science leveling in medical studies.
A new anti-time tool
Parkinson is now a faster neurological disease in the world.Its symptoms can be released - Flamblo, hard, slow movements - with drugs, but there is still no treatment that stops its progress.
Psychiatrist Michele Matarazzo, who is not involved in this study, is respected by the SMC agent that this tool can open the door to get a better understanding of how and at this time it is created and what its role in the disease."of Neurologist in Parkinson's disease by Cinac Cinac Center neuroscience.
For your part, Ventura Ventura, who does not participate in work, also the name of the display name, "says the till the science means the science technique (I3PT-Carca) in Saladill.
Scientists for the first time have been able to see and measure directly in human brain tissue small protein coats that are held responsible for the launch of Parkinsona.It will not reach 25 million patients in 2050.